Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment

Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment. Cardiovascular morbidity and mortality importantly influence live expectancy of patients with chronic renal disease (CKD). Traditional risk factors are usually present, but several other factors hav...

Full description

Saved in:
Bibliographic Details
Published in:Kidney international Vol. 65; no. 5; pp. 1568 - 1576
Main Authors: Neumann, Jutta, Ligtenberg, Gerry, Klein, Inge I., Koomans, Hein A., Blankestijn, Peter J.
Format: Journal Article Conference Proceeding
Language:English
Published: New York, NY Elsevier Inc 01-05-2004
Nature Publishing
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment. Cardiovascular morbidity and mortality importantly influence live expectancy of patients with chronic renal disease (CKD). Traditional risk factors are usually present, but several other factors have recently been identified. There is now evidence that CKD is often characterized by an activated sympathetic nervous system. This may contribute to the pathogenesis of renal hypertension, but it may also adversely affect prognosis independently of its effect on blood pressure. The purpose of this review is to summarize available knowledge on the role of the sympathetic nervous system in the pathogenesis of renal hypertension, its clinical relevance, and the consequences of this knowledge for the choice of treatment.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0085-2538
1523-1755
DOI:10.1111/j.1523-1755.2004.00552.x